AI assistant
BIOGEN INC. — Director's Dealing 2013
May 1, 2013
30291_dirs_2013-05-01_9d097978-ebce-4abd-b885-ad6df92222b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-04-29
Reporting Person: Clancy Paul J (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-29 | Common Stock | S | 9123 | $219.71 | Disposed | 21576 | Direct |
| 2013-04-30 | Common Stock | S | 1968 | $222.5693 | Disposed | 19608 | Direct |
| 2013-04-30 | Common Stock | S | 5380 | $224.3443 | Disposed | 14228 | Direct |
| 2013-04-30 | Common Stock | S | 6241 | $225.3959 | Disposed | 7987 | Direct |
| 2013-04-30 | Common Stock | S | 900 | $226.0078 | Disposed | 7087 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This represents the weighted average price for shares sold at a range between $222.27 (low) and $222.96 (high).
F3: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F4: This represents the weighted average price for shares sold at a range between $223.87 (low) and $224.84 (high).
F5: This represents the weighted average price for shares sold at a range between $224.92 (low) and $225.91 (high).
F6: This represents the weighted average price for shares sold at a range between $225.95 (low) and $226.08 (high).